Related Experiment Videos
Myocardial viability in ischemic heart disease: new directions and perspectives
1Department of Cardiology, IRCCS Policlinico San Matteo, University of Pavia School of Medicine, Italy. marprevi@tin.it
Insights
Detecting myocardial viability is crucial for ischemic heart disease patients, guiding treatment decisions and predicting recovery after revascularization. Nuclear and echocardiographic methods assess viability, with dobutamine echocardiography offering higher specificity for predicting functional recovery.
Area of Science:
- Cardiology
- Nuclear Medicine
- Echocardiography
Background:
- Myocardial viability assessment is critical for ischemic heart disease (IHD) patients, influencing therapeutic strategies and prognosis.
- Reversible left ventricular dysfunction in IHD stems from mechanisms like hibernation and stunning, impacting functional recovery post-revascularization.
- Understanding these mechanisms is key to tailoring treatment and predicting outcomes.
Purpose of the Study:
- To review current methods for detecting myocardial viability in IHD.
- To discuss the prognostic significance of myocardial viability in patients with left ventricular dysfunction.
- To highlight emerging techniques for comprehensive viability assessment.
Main Methods:
- Current clinical assessment relies on nuclear techniques (tracer uptake/metabolism) and echocardiography (contractile reserve).
- Dobutamine echocardiography shows higher specificity than nuclear methods in predicting functional recovery.
- New developments focus on quantifying viable myocardium and assessing metabolism, perfusion, and function simultaneously.
Main Results:
- Both nuclear and echocardiographic methods demonstrate similar sensitivity for predicting functional recovery.
- Dobutamine echocardiography is more specific, potentially offering greater clinical utility.
- Patients with significant viable myocardium show marked survival benefits and improved function after revascularization.
Conclusions:
- Preoperative quantification of myocardial viability is essential for identifying IHD patients who will benefit from revascularization, especially those with severe left ventricular dysfunction.
- Emerging techniques like Doppler tissue imaging and contrast echocardiography promise more comprehensive viability assessment.
- The benefit of revascularization on survival in patients with limited viability requires further investigation.
Abstract:
In patients with ischemic heart disease detection of myocardial viability is of major clinical and prognostic importance and may significantly affect therapeutic decisions. Reversible left ventricular dysfunction may be due to different pathophysiological mechanisms, including myocardial hibernation and stunning, structural and ultrastructural myocardial changes and alterations in gene expression leading to myocardial cell dedifferentiation. Each of these mechanisms may have different importance related to the clinical history of the patient and severity and duration of left ventricular dysfunction and may significantly influence the extent and time course of functional recovery after myocardial revascularization. In the clinical arena detection of myocardial viability is currently based on the use of nuclear techniques, which show preserved tracer uptake and metabolism in viable myocardium and echocardiographic methods, which detect residual contractile reserve. Both techniques show a similar sensitivity in predicting functional recovery after revascularization, but dobutamine echocardiography has a higher specificity and therefore may be clinically more useful. Due to the limitations of current nuclear and echocardiographic methods in detecting myocardial viability, new developments are directed towards better quantification of viable myocardium and simultaneous assessment of myocardial metabolism, perfusion and function. Doppler tissue imaging, intravenous contrast echocardiography and ECG-gated SPECT with combined evaluation of metabolism and perfusion seem to be the most promising and cost-effective methods for a comprehensive assessment of myocardial viability. The major prognostic importance of myocardial viability in patients with severe left ventricular dysfunction is demonstrated by the fact that patients with a significant amount of viable myocardium have a marked survival benefit from revascularization and an improvement in left ventricular function and NYHA functional class compared with those without or only marginal viability. Thus, in patients with severe dysfunction preoperative quantification of viable myocardium is of utmost importance to identify patients who can benefit from revascularization. In patients with lesser amount of viable myocardium the possible beneficial effect of revascularization on survival, even in the absence of significant improvement in ventricular function, is yet to be demonstrated and should be assessed in future prospective clinical trials.